CONTACTS 

SUBJECTS
Cetuximab 12th Cycle 3rd Treatment 18th Total Treatment Chemotherapy

0403 -
0403 -    ..
0404 - Summary/Objective
0405 -
040501 - Follow up ref SDS A0 0000. ref SDS 99 0000.
040502 -
040503 -
040504 -
040505 -
040506 -
040507 -
040508 -
040509 -
040510 -
040512 -  ..
0406 -
0407 -
0408 - Progress
0409 -
040901 - Background on Millie's treatment in the clinical study is reported on
040902 - 080508. ref SDS 94 TZ8I
040904 -    ..
040905 -   Taxotere Capecitabine 2nd Relapse IBC Treatment After Mastectomy
040906 -
040907 -   Follow up ref SDS A0 X33O, ref SDS 99 X33O.
040908 -
040909 -   Millie had left mastectomy on 051021.  Biopsy at that time reported
040910 -   no findings of cancer.  Approximately 8 months later on 060707 the
040911 -   doctor diagnosed IBC relapse and prescribed treatment. ref SDS 2
040912 -   PF3O
040913 -
040914 -    1.  Cycle 09 and 01 ................... 060721, ref SDS 3 407N
040915 -    2.  Cycle 10 and 02 ................... 060814, ref SDS 5 LY6O
040916 -    3.  Cycle 11 and 03 ................... 060908, ref SDS 5 407N
040917 -    4.  Cycle 12 and 04 ................... 060929, ref SDS 5 407N
040918 -    5.  Cycle 13 and 05 ................... 061020, ref SDS 6 407N
040919 -    6.  Cycle 14 and 06 ................... 061110, ref SDS 7 407N
040920 -    7.  Cycle 15 and 07 ................... 061201, ref SDS 8 407N
040922 -    ..
040923 -   Cetuxiab Alone Clinical Study
040924 -
040925 -   Follow up ref SDS A0 356I, ref SDS 99 356I.
040926 -
040927 -                   Total    Cetuximab
040928 -    8.  Cycle 01 and 08 and 01 01.......... 070201, ref SDS 10 SG8I
040929 -    9.  Cycle 01 and 08 and 02 02.......... 070208, ref SDS 11 SG8I
040930 -   10.  Cycle 01 and 08 and 03 03.......... 070215, ref SDS 12 SG8I
040931 -   11.  Cycle 01 and 08 and 04 04.......... 070222, ref SDS 13 SG8I
040932 -   12.  Cycle 02 and 09 and 01 05.......... 070301, ref SDS 14 SG8I
040933 -   13.  Cycle 02 and 09 and 02 06.......... 070308, ref SDS 16 7T3H
040934 -   14.  Cycle 02 and 09 and 03 07.......... 070315, ref SDS 17 7T3H
040935 -   15.  Cycle 02 and 09 and 04 08.......... 070322, ref SDS 18 7T3H
040936 -   16.  Cycle 03 and 10 and 01 09.......... 070329, ref SDS 19 7T3H
040937 -   17.  Cycle 03 and 10 and 02 10.......... 070405, ref SDS 20 7T3H
040938 -   18.  Cycle 03 and 10 and 03 11.......... 070412, ref SDS 21 7T3H
040939 -   19.  Cycle 03 and 10 and 04 12.......... 070419, ref SDS 22 7T3H
040940 -   20.  Cycle 04 and 11 and 01 13.......... 070426, ref SDS 23 7T3H
040941 -   21.  Cycle 04 and 11 and 02 14.......... 070503, ref SDS 24 7T3H
040942 -   22.  Cycle 04 and 11 and 03 15.......... 070510, ref SDS 25 7T3H
040943 -   23.  Cycle 04 and 11 and 04 16.......... 070517, ref SDS 26 7T3H
040944 -   24.  Cycle 05 and 12 and 01 17.......... 070524, ref SDS 27 7T3H
040945 -   25.  Cycle 05 and 12 and 02 18.......... 070531, ref SDS 28 7T3H
040946 -   26.  Cycle 05 and 12 and 03 19.......... 070607, ref SDS 29 7T3H
040947 -   27.  Cycle 05 and 12 and 04 20.......... 070614, ref SDS 30 0001
040948 -   28.  Cycle 06 and 13 and 01 21.......... 070621, ref SDS 31 0001
040949 -   29.  Cycle 06 and 13 and 02 22.......... 070628, ref SDS 32 0001
040950 -   30.  Cycle 06 and 13 and 03 23.......... 070705, ref SDS 33 0001
040951 -   31.  Cycle 06 and 13 and 04 24.......... 070712, ref SDS 33 0001
040952 -   32.  Cycle 07 and 14 and 01 25.......... 070719, ref SDS 35 0001
040953 -   33.  Cycle 07 and 14 and 02 26.......... 070726, ref SDS 32 0001
040954 -   34.  Cycle 07 and 14 and 03 27.......... 070802, ref SDS 33 0001
040955 -   35.  Cycle 07 and 14 and 04 28.......... 070809, ref SDS 37 0001
040956 -   36.  Cycle 08 and 15 and 01 29.......... 070816, ref SDS 38 0001
040957 -   37.  Cycle 08 and 15 and 02 30.......... 070823, ref SDS 39 0001
040958 -   38.  Cycle 08 and 15 and 03 31.......... 070830, ref SDS 39 0001
040959 -   39.  Cycle 08 and 15 and 04 32.......... 070906, ref SDS 40 0001
040960 -   40.  Cycle 09 and 16 and 01 33.......... 070920, ref SDS 41 0001
040961 -   41.  Cycle 09 and 16 and 02 34.......... 070927, ref SDS 42 0001
040962 -   42.  Cycle 09 and 16 and 03 35.......... 071004, ref SDS 43 0001
040963 -   43.  Cycle 09 and 16 and 04 36.......... 071011, ref SDS 44 0001
040964 -   44.  Cycle 10 and 17 and 01 37.......... 071018, ref SDS 45 0001
040965 -   45.  Cycle 10 and 17 and 02 38.......... 071025, ref SDS 46 0001
040966 -   46.  Cycle 10 and 17 and 03 39.......... 071101, ref SDS 30 0001
040967 -   47.  Cycle 10 and 17 and 04 40.......... 071108, ref SDS 48 0001
040968 -   48.  Cycle 11 and 18 and 01 41.......... 071115, ref SDS 49 0001
040969 -   49.  Cycle 11 and 18 and 02 42.......... 071122, ref SDS 32 0001
040970 -   50.  Cycle 11 and 18 and 03 43.......... 071129, ref SDS 51 0001
040971 -   51.  Cycle 11 and 18 and 04 44.......... 071206, ref SDS 52 0001
040972 -   52.  Cycle 12 and 19 and 01 45.......... 071213, ref SDS 55 0001
040973 -   53.  Cycle 12 and 19 and 02 46.......... 071220, ref SDS 58 0001
040974 -   54.  Cycle 12 and 19 and 03 47.......... 071227, ref SDS 59 0001
040975 -   55.  Cycle 12 and 19 and 04 48.......... 080103, ref SDS 60 0001
040976 -   56.  Cycle 13 and 20 and 01 49.......... 080110, ref SDS 63 0001
040977 -   57.  Cycle 13 and 20 and 02 50.......... 080117, ref SDS 64 0001
040978 -   58.  Cycle 13 and 20 and 03 51.......... 080124, ref SDS 65 0001
040979 -   59.  Cycle 13 and 20 and 04 52.......... 080131, ref SDS 67 0001
040980 -   60.  Cycle 14 and 21 and 01 53.......... 080207, ref SDS 71 0001
040981 -   61.  Cycle 14 and 21 and 02 54.......... 080214, ref SDS 72 0001
040982 -   62.  Cycle 14 and 21 and 03 55.......... 080221, ref SDS 33 0001
040983 -   63.  Cycle 14 and 21 and 04 56.......... 080228, ref SDS 77 0001
040984 -   64.  Cycle 15 and 22 and 01 57 01  00... 080306, ref SDS 80 TZ8I
040986 -    ..
040987 -   Cetuxiab with Carboplatin Clinical Study 2nd Arm
040988 -
040989 -   Follow up ref SDS A0 5B6J, ref SDS 99 5B6J.
040990 -
040991 -   On 080207 doctor reports IBC may be spreading. ref SDS 70 GH5H
040992 -   Follow up examination on 080219 Doctor Rugo diagnosed progression of
040993 -   disease. ref SDS 90 3J4I  Photographs show spread of IBC rash,
040994 -
040995 -             2nd
040996 -             Arm              Cetuximab Carboplatin
040997 -   65.  Cycle 01 15 and 22 and 02 58 02  01... 080313, ref SDS 81 TZ8I
040998 -   66.  Cycle 01 15 and 22 and 03 59 03  01... 080320, ref SDS 82 TZ8I
040999 -   67.  Cycle 01 15 and 22 and 04 60 04  01... 080327, ref SDS 83 TZ8I
041000 -   68.  Cycle 02 16 and 23 and 01 61 05  02... 080403, ref SDS 84 TZ8I
041001 -   69.  Cycle 02 16 and 23 and 02 62 06  03... 080410, ref SDS 87 TZ8I
041002 -   70.  Cycle 02 16 and 23 and 03 63 07  03... 080417, ref SDS 89 TZ8I
041003 -   71.  Cycle 02 16 and 23 and 04 64 08  03... 080424, ref SDS 91 TZ8I
041004 -   72.  Cycle 03 17 and 24 and 01 65 09  04... 080501, ref SDS 92 5B6J
041005 -   73.  Cycle 03 17 and 24 and 02 66 10  05... 080508, ref SDS 94 5B6J
041006 -   74.  Cycle 03 17 and 24 and 03 67 11  05... 080515, ref SDS 95 5B6J
041007 -   75.  Cycle 03 17 and 24 and 04 68 12  05... 080522, ref SDS 96 5B6J
041008 -   76.  Cycle 04 18 and 25 and 01 69 13  06... 080529, ref SDS 98 5B6J
041009 -   77.  Cycle 04 18 and 25 and 02 70 14  07... 080605, ref SDS 99 5B6J
041010 -   78.  Cycle 04 18 and 25 and 03 71 15  08... 080612, ref SDS A0 5B6J
041011 -   79.  Cycle 04 18 and 25 and 04 72 16  08... 080619, ref SDS 0 5B6J
041013 -  ..
041014 - Today is the 4rd treatment of the 4th cycle with cetuximab and
041015 - Carboplatin together.  This is the 16th treatment overall with
041016 - cetuximab on the 2nd arm of the clinical study, but is only the 8th
041017 - treatment with Carboplatin due to low blood counts.
041019 -  ..
041020 - Today is a bye week for Carboplatin.
041022 -  ..
041023 - Catherine was Millie's nurse today.
041024 -
041025 -
0411 -

SUBJECTS
Default Null Subject Account for Blank Record

0503 -
050401 -  ..
050402 - Labs Blood Test
050403 -
050404 - Follow up ref SDS A0 FW5N, ref SDS 99 FW5N.
050405 -
050406 - Adding Carboplatin to the treatment protocol now requires weekly blood
050407 - tests to determine if the immune system is strong enough for safe
050408 - chemotherapy treatment, reported on 070201, ref SDS 10 XR40, and citing
050409 - the clinical study protocol received from UCSF on 070116. ref SDS 9
050410 - 5U7Z
050412 -  ..
050413 - During treatment, Catherine submitted results of the test.
050414 -
050429 -     ..
050430 -    Log#:                   080619 08:10
050431 -    <----------------------- U C S F -----------------------> <-------------  Kaiser -------------->
050432 -    Type                 Results   Units        Normal        ACRO   Type            Units        Normal
050433 -     ..
050434 -    CBC with DIFF & PLT CT                                     CBCD
050435 -     ..
050436 -    WBC COUNT      L        2.4    x10E9/L     3.4  -   10     WBC   WBC x10-3        K/uL     3.4  -  10.0
050437 -    RBC COUNT      L        3.70   x10E12/L      4  -   5.2    RBC   RBC x10-6        M/uL    3.60  -  5.70
050438 -    HEMOGLOBIN             12.3    g/dL         12  -   15.5   HGB   Hemoglobin       g/dL    11.5  -  15.0
050439 -    HEMATOCRIT     L       35.7    PERCENT      36  -   46     HCT   Hematocrit       %       34.0  -  46.0
050440 -    MCV                    96      fL           80  -   100    MCV   MCV              fL      80.0  -  100.0
050441 -    MCH                    33.2    pg           26  -   34     MCH
050442 -    MCHC                   34.4    g/dL         31  -   36     MCHC
050443 -    PLATELETS             221      x10E9/L     140  -  450     PLT   Plt x10-3        K/uL     140  -  400
050444 -
050445 -        Performed at Mt Zion Clinic Lab, 1600 Divisadero, San
050446 -        Francisco, CA  94115
050447 -    ..
050448 -     (NEUTS x 1000 = ANC for Kaiser)
050449 -    NEUTS         L         0.74   x10E9/L     1.8  -  6.8     N-A   ANC                      1500
050450 -    Neutrophils    Not Reported                                      Neutrophils       %        50  -  70
050452 -     ..
050453 -    LYMPHS                  1.29   x10E9/L     0.9  -  2.9     L-A   Lymphocytes       %        20  -  50
050454 -    MONOS                   0.25   x10E9/L     0.1  -  0.6     M-A   Monocyte          %         0  -  11
050455 -    EOS                     0.09   x10E9/L       0  -  0.4     E-A   Esoinophils       %         1  -  5
050456 -    BASOS                   0.06   x10E9/L       0  -  0.1     B-A   Basophil          %         0  -  2
050457 -
050459 -  ..
050460 - Blood counts decreased significantly this week shown by the report
050461 - today with NEUTS 0.74, ref SDS 0 QY6H, compared with NEUTS 3.77 last
050462 - week on 080612, ref SDS A0 QY6H  Significant decline in blood counts
050463 - today reflects getting Carboplatin chemotherapy treatment last week on
050464 - 080612 without getting Neupogen treatments, which follows the
050465 - Chemotheapy Orders on 080529, received a week earlier on 080605.
050466 - ref SDS 99 JN38
050468 -  ..
050469 - Big drops in blood counts continue to conflict with Millie's evident
050470 - strength and energy, shown by the report of Millie climbing up the Mt
050471 - Diablo trail 3.5 miles to Deer Flat, a 7 mile hike, and by far the
050472 - most vigorous exercise she has accomplished since being diagnosed with
050473 - cancer in February of 2002, 7 years ago. ref SDS A1 IZ5I
050475 -  ..
050476 - Catherine notified the medical team about Millie's low blood counts
050477 - today.
050479 -  ..
050480 - Catherine explained instructions from the doctor (perhaps Brigid) that
050481 - since blood counts are very low today, NEUTS 0.74, ref SDS 0 QY6H, and
050482 - since next week starts a new cycle and so will include Carboplatin
050483 - chemotherapy treatment, and further since Millie received no
050484 - Carboplatin today on the bye week for chemotherapy in the current
050485 - cycle, then therefore Millie needs only one (1) Neupogen treatment
050486 - this week in order to increase blood counts for safe treatment next
050487 - Thursday, 080626.
050488 -
050489 -        [On 080619 Millie confirmed instructions to get 1 Neupogen
050490 -        treatment at Kaiser, ref SDS A2 YU6S; and requested feedback
050491 -        from UCSF to verify this understanding in light of blood counts
050492 -        lowest ever. ref SDS A2 YU8W
050494 -         ..
050495 -        [On 080620 UCSF confirmed prescription for only 1 Neupogen
050496 -        treatment this week, since Millie did not get Carboplating
050497 -        chemotherapy this week. ref SDS A3 YY5H
050499 -         ..
050500 -        [On 080620 Millie went to Kaiser and got treatment with
050501 -        Neupogen, ref SDS A3 016C, and cancelled the 2nd treatment
050502 -        scheduled for Saturday on 080621, per UCSF guidance.
050503 -        ref SDS A3 BE6K
050504 -
050505 -
050506 -
050507 -
050508 -
050509 -
050510 -
050511 -
050512 -
050513 -
0506 -